Table.
Mean Score and Percent Reduction in Clinical Symptoms of AR with INS Compared with Saline Over 8 Weeks.2
| Week | Steroid Group | Saline Group | ||
|---|---|---|---|---|
| Mean Clinical Symptom Score* |
Percent Reduction |
Mean Clinical Symptom Score* |
Percent Reduction |
|
| Week 0 | 11.2 | -- | 10.5 | -- |
| Week 2 | 3.9 | 65% | 9.3 | 11% |
| Week 4 | 3.5 | 10% | 9.4 | −1% |
| Week 6 | 3.5 | 0% | 8.7 | 7% |
| Week 8 | 3.4 | 3% | 8.9 | −2% |
| Net Percent Reduction | 70% | 18% | ||
*
Mean Clinical Symptom Score calculated for 6 symptoms on a 0-3 scale with 0 = no symptoms and 3 = intense symptoms. Total possible clinical score = 18.
Adapted from de Souza Campos Fernandes et al., 2014.2